Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action

Molecular and Cellular Biology

Volumn 24, Issue 11, 2004, Pages 5005-5015

  Vigliotta, Giovanni ^a,b,d   Miele, Claudia ^a,b,d   Santopietro, Stefania ^a,b   Portella, Giuseppe ^a,b   Perfetti, Anna ^a,b   Maitan, Maria Alessandra ^a,b   Cassese, Angela ^a,b   Oriente, Francesco ^a,b   Trencia, Alessandra ^a,b   Fiory, Francesca ^a,b   Romano, Chiara ^a,b   Tiveron, Cecilia ^c   Tatangelo, Laura ^c   Troncone, Giancarlo ^a   Formisano, Pietro ^a,b   Beguinot, Francesco ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISINDOLYLMALEIMIDE; COMPLEMENTARY DNA; GLUCOSE; INSULIN; PED PEA 15 PROTEIN; PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PED PEA 15 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; DIABETES MELLITUS; GLUCOSE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INSULIN; MICE; MICE, TRANSGENIC; PHOSPHOPROTEINS;

ANIMALIA; MUS MUSCULUS; PISUM SATIVUM;

EID: 2442675414     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.11.5005-5015.2004     Document Type: Article

References (37)

1. Arner, P. 2002. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab. Res. Rev. 18(Suppl. 2):S5-S9.
2. Bell, G. I., and K. S. Polonsky. 2001. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788-791.
3. Boden, G., and G. I. Shulman. 2002. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Investig. 32(Suppl. 3):14-23.
4. Caruso, M., C. Miele, A. Oliva, G. Condorelli, F. Oriente, G. Riccardi, B. Capaldo, F. Fiory, D. Accili, P. Formisano, and F. Beguinot. 2000. The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes 49:1194-1202.
5. Condorelli, G., A. Trencia, G. Vigliotta, A. Perfetti, U. Goglia, A. Cassese, A. M. Musti, C. Miele, S. Santopietro, P. Formisano, and F. Beguinot. 2002. Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J. Biol. Chem. 277:11013-11018.
6. Condorelli, G., G. Vigliotta, A. Cafieri, A. Trencia, P. Andalo, F. Oriente, C. Miele, M. Caruso, P. Formisano, and F. Beguinot. 1999. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18:4409-4415.
7. Condorelli, G., G. Vigliotta, C. Iavarone, M. Caruso, C. G. Tocchetti, F. Andreozzi, A. Cafieri, M. F. Tecce, P. Formisano, L. Beguinot, and F. Beguinot. 1998. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 17:3858-3866.
8. Condorelli, G., G. Vigliotta, A. Trencia, M. A. Maitan, M. Caruso, C. Miele, F. Oriente, S. Santopietro, P. Formisano, and F. Beguinot. 2001. Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50:1244-1252.
9. Czech, M. P. 1980. Insulin action and the regulation of hexose transport. Diabetes 39:399-409.
10. DeFronzo, R. A. 1995. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177-269.
11. Estelles, A., C. A. Charlton, and H. M. Blau. 1999. The phophoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev. Biol. 216:16-28.
12. Farese, R. V. 2002. Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am. J. Physiol. Endocrinol. Metab. 283:E1-E11.
13. Filippa, N., C. L. Sable, C. Filloux, B. Hemmings, and E. Van Obberghen. 1999. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 19:4989-5000.
14. Formstecher, E., J. W. Ramos, M. Fauquet, D. A. Calderwood, J. C. Hsieh, B. Canton, X. T. Nguyen, J. V. Barnier, J. Camonis, M. H. Ginsberg, and H. Chneiweiss. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1:239-250.
15. Hao, C., F. Beguinot, G. Condorelli, A. Trencia, E. G. Van Meir, V. W. Yong, I. F. Parney, W. H. Roa, and K. C. Petruk. 2001. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res. 61:1162-1170.
16. Kahn, C. R. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084.
17. Kanoh, Y., G. Bandyopadhyay, M. P. Sajan, M. L. Standaert, and R. V. Farese. 2000. Thiazolidinedione treatment enhances insulin effects on protein kinase C-ζ/λ activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats. J. Biol. Chem. 275:16690-16696.
18. Kanoh, Y., G. Bandyopadhyay, M. P. Sajan, M. L. Standaert, and R. V. Farese. 2001. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-ζ/λ by insulin in vastus laterlais muscles and adipocytes of diabetic rats. Endocrinology 142:1595-1605.
19. Kim, Y. B., K. Kotani, T. P. Ciaraldi, R. V. Farese, R. R. Henry, and B. B. Kahn. 2001. Insulin-stimulated PKCζ/λ activity is impaired in muscles of insulin resistant subjects. Diabetes 250(Suppl. 2):A62.
20. Kim, Y. B., S. E. Nikoulina, T. P. Ciaraldi, R. R. Henry, and B. B. Kahn. 1999. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phophoinositide 3-kinase in muscle in type 2 diabetes. J. Clin. Investig. 104:733-741.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Leitges, M., M. Plomann, M. L. Standaert, G. Bandyopadhyay, M. P. Sajan, Y. Kanoh, and R. V. Farese. 2002. Knockout of PKCα enhances insulin signaling through PI3K. Mol. Endocrinol. 16:847-858.
23. Miyazaki, J., K. Araki, E. Yamato, H. Ikegami, T. Asano, Y. Shibasaki, Y. Oka, and K. Yamamura. 1990. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132.
24. Pinget, M., and S. Boullu-Sanchis. 2002. Physiological basis of insulin secretion abnormalities. Diabetes Metab. 28(Suppl. 6):S7-S13.
25. Preiss, J. E., C. R. Loomis, R. M. Bell, and J. E. Niedel. 1987. Quantitative measurement of sn-1,2-diacylglycerols. Methods Enzymol. 141:294-299.
26. Qu, X., J. P. Seale, and R. Donnelly. 1999. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats-effects of feeding. J. Endocrinol. 162:207-214.
27. Reaven, G. M. 1988. Role of insulin resistance in human diabetes. Diabetes 37:1595-1607.
28. Rodbell, M. 1964. Metabolism of isolated fat cells. J. Biol. Chem. 239:173-181.
29. Russ, M., A. Wichelhaus, I. Uphues, T. Kolter, and J. Eckel. 1994. Photoaffinity labelling of cardiac membrane GTP-binding proteins in response to insulin. Eur. J. Biochem. 219:325-330.
30. Trencia, A., A. Perfetti, A. Cassese, G. Vigliotta, C. Miele, F. Oriente, S. Santopietro, F. Giacco, G. Condorelli, P. Formisano, and F. Beguinot. 2003. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol. Cell. Biol. 23:4511-4521.
31. Turinsky, J., B. P. Bayly, and D. M. O'Sullivan. 1990. 1, 2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. J. Biol. Chem. 265:7933-7938.
32. Uphues, I., T. Kolter, B. Goud, and J. Eckel. 1995. Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. Biochem. J. 311:161-166.
33. White, M. F. 2002. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283:E413-E422.
34. Xiao, C., B. F. Yang, N. Asadi, F. Beguinot, and C. Hao. 2002. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277:25020-25025.
35. Zhang, Y., O. Redina, Y. M. Altshuller, M. Yamazaki, J. Ramos, H. Chneiweiss, Y. Kanaho, and M. A. Frohman. 2000. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J. Biol. Chem. 275:35224-35232.
36. Zimmet, P., K. G. Alberti, and J. Sbaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782-787.
37. Zisman, A., O. D. Peroni, E. D. Abel, M. D. Michael, F. Mauvais-Jarvis, B. B. Lowell, J. F. Wojtaszewski, M. F. Hirshman, A. Virkamaki, L. J. Goodyear, C. R. Kahn, and B. B. Kahn. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924-928.